Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rencofilstat in NASH F2/F3
NCT04480710Phase 2Completed
- Sponsor
- Hepion Pharmaceuticals
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of rencofilstat in Nonalcoholic steatohepatitis (NASH), sponsored by Hepion Pharmaceuticals. Started Jun 2020; status: completed.
02
Drugs
rencofilstat
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04480710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04480710.